American Oncology Network (AONCW) Stock Price, News & Analysis

Company Overview

American Oncology Network, Inc. (NASDAQ:AONCW) is a community-based oncology platform that supports independent medical practices providing cancer and hematology care. The company’s network includes oncology and hematology providers, infusion services, and related outpatient care facilities serving patients in communities across the United States.

American Oncology Network provides practice-management and administrative services designed to help physicians operate independently while accessing shared technology, clinical resources, revenue-cycle support, data and analytics, specialty pharmacy services, and opportunities to participate in clinical research and value-based care programs. Its affiliated practices diagnose and treat a range of cancers and blood disorders through medical oncology, hematology, infusion therapy, and supportive-care services.

Founded by community oncologists in 2018, the company was created to expand access to coordinated cancer care outside major hospital systems. In 2024, McKesson announced an agreement to acquire a controlling interest in American Oncology Network, linking the organization with McKesson’s broader oncology-services operations. American Oncology Network has historically focused on supporting physician-led practices across multiple U.S. markets.

Key Stats

• Today's Range: $0.0007 to $0.0007
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $1.83
• Volume: N/A
• Average Volume: 856 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: N/A
• Current Symbol: NASDAQ:AONCW
• CIK: 1839998
• Web: www.aoncology.com
• Phone: 833-886-1725
• Fax: N/A
• Employees: 1,525
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.34 billion
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A